PAPP-A Human, Native

SKU:BHZ11000328
Catalog / Quick links
    Overview
    Click light‑blue chips for details
    Progastricsin-C Human Recombinant PAPPA is a large zinc binding protein, which plays a role as a metalloprotease and specifically cleaves IGFBP-4 and IGFBP-5, resulting in release of bound IGF. PAPP-A regulates IGF bioactivity in various biological systems, including the human ovary and cardiovascular systems. PAPP A levels were higher in patients with unstable angina or acute myocardial infarction. PAPPA is also involved in local proliferative processes such as wound healing and bone remodeling. Moreover, PAPP-A is produced in high concentrations during pregnancy and is released into the maternal circulation. In placenta, PAPP A is expressed in X cells in septa and anchoring villi, and in syncytiotrophoblasts in the chorionic villi.
    Enzyme Type Other Enzymes
    Species Human
    Form Lyophilized
    Expression System Human Placenta
    Purity 95.0%
    Gene Symbol PAPP-A Native
    Source Human Placenta
    Available Options
    20µg | 100µg | 1mg
    Options selector
    Catalog no. Size
    ENZ-1204-20µg 20µg
    ENZ-1204-100µg 100µg
    ENZ-1204-1mg 1mg
    Field Specification
    Enzyme Type
    • Other Enzymes
    Expression System
    • Human Placenta
    Form Lyophilized
    Formulation PAPP-A protein was lyophilized from 10mM Tris-HCl pH-7, 0.15M NaCl, 0.1% NGME & 0.09% NaN3.
    Product Type
    • Enzyme
    Purity 95.0%
    Source Human Placenta
    Species Human
    Storage Lyophilized PAPP-A although stable at room temperature for 3 weeks, should be stored desiccated below -18C. Upon reconstitution PAPP-A should be stored at 4C between 2-7 days and for future use below -18C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
    Target PAPP-A Native

    Product Description

    Progastricsin-C Human Recombinant

    Overview

    PAPPA is a large zinc binding protein, which plays a role as a metalloprotease and specifically cleaves IGFBP-4 and IGFBP-5, resulting in release of bound IGF. PAPP-A regulates IGF bioactivity in various biological systems, including the human ovary and cardiovascular systems. PAPP A levels were higher in patients with unstable angina or acute myocardial infarction. PAPPA is also involved in local proliferative processes such as wound healing and bone remodeling. Moreover, PAPP-A is produced in high concentrations during pregnancy and is released into the maternal circulation. In placenta, PAPP A is expressed in X cells in septa and anchoring villi, and in syncytiotrophoblasts in the chorionic villi.

    Specifications

    Purity Greater than 95.0% as determined by SDS-PAGE.
    Formulation PAPP-A protein was lyophilized from 10mM Tris-HCl pH-7, 0.15M NaCl, 0.1% NGME & 0.09% NaN3.
    Storage Lyophilized PAPP-A although stable at room temperature for 3 weeks, should be stored desiccated below -18C. Upon reconstitution PAPP-A should be stored at 4C between 2-7 days and for future use below -18C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
    Expression System Human Placenta

    Get a Quote

    Please use this form for bulk quantity requests or customized products.

    Contact Information

    Product Information

    Supplier Ads Slides show

    Add dynamic ads with slider